293 related articles for article (PubMed ID: 19671858)
21. Small-molecule signal-transduction inhibitors: targeted therapeutic agents for single-gene disorders.
Davies DM; Sampson JR
J Med Genet; 2010 Mar; 47(3):145-9. PubMed ID: 19752156
[TBL] [Abstract][Full Text] [Related]
22. Scaffold/matrix attachment regions (S/MARs): relevance for disease and therapy.
Gluch A; Vidakovic M; Bode J
Handb Exp Pharmacol; 2008; (186):67-103. PubMed ID: 18491049
[TBL] [Abstract][Full Text] [Related]
23. Epigenome-derived drugs: recent advances and future perspectives.
Vogiatzi P; Aimola P; Scarano MI; Claudio PP
Drug News Perspect; 2007 Dec; 20(10):627-33. PubMed ID: 18301797
[TBL] [Abstract][Full Text] [Related]
24. Focus on Fotemustine.
De Rossi A; Rossi L; Laudisi A; Sini V; Toppo L; Marchesi F; Tortorelli G; Leti M; Turriziani M; Aquino A; Bonmassar E; De Vecchis L; Torino F
J Exp Clin Cancer Res; 2006 Dec; 25(4):461-8. PubMed ID: 17310834
[TBL] [Abstract][Full Text] [Related]
25. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.
Motegi A; Murakawa Y; Takeda S
Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084
[TBL] [Abstract][Full Text] [Related]
26. New radiosensitizing regimens, drugs, prodrugs, and candidates.
Vallerga AK; Zarling DA; Kinsella TJ
Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
[TBL] [Abstract][Full Text] [Related]
27. Targeted cancer therapeutics.
Hait WN; Hambley TW
Cancer Res; 2009 Feb; 69(4):1263-7; discussion 1267. PubMed ID: 19208830
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of drugs to modulate DNA repair in cancer.
Curtin N
Expert Opin Ther Targets; 2007 Jun; 11(6):783-99. PubMed ID: 17504016
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of UV-induced DNA excision repair by chemotherapeutic drugs in cancer patients.
Roth M; Rogers S; Roberts SS; Boyle JM; Müller HJ; Weber W
Anticancer Res; 1994; 14(3A):809-15. PubMed ID: 8074483
[TBL] [Abstract][Full Text] [Related]
30. Genetic and epigenetic regulations of prostate cancer by genistein.
Molinié B; Georgel P
Drug News Perspect; 2009 Jun; 22(5):247-54. PubMed ID: 19609462
[TBL] [Abstract][Full Text] [Related]
31. Targeting the DNA damage response in cancer.
Ljungman M
Chem Rev; 2009 Jul; 109(7):2929-50. PubMed ID: 19545147
[No Abstract] [Full Text] [Related]
32. Targeting epigenetic regulatory mechanisms in cancer chemoprevention.
Fay JR; Crowell JA; Kopelovich L
Expert Opin Ther Targets; 2005 Apr; 9(2):315-28. PubMed ID: 15934918
[TBL] [Abstract][Full Text] [Related]
33. Targeting DNA repair as a promising approach in cancer therapy.
Damia G; D'Incalci M
Eur J Cancer; 2007 Aug; 43(12):1791-801. PubMed ID: 17588740
[TBL] [Abstract][Full Text] [Related]
34. The molecular basis of cancer and the development of targeted therapy.
Riley LB; Desai DC
Surg Clin North Am; 2009 Feb; 89(1):1-15, vii. PubMed ID: 19186227
[TBL] [Abstract][Full Text] [Related]
35. Identifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future.
Showalter SL; Charles S; Belin J; Cozzitorto J; Einstein P; Richards NG; Sauter PK; Kennedy EP; Witkiewicz A; Brody JR; Yeo CJ
Expert Opin Drug Deliv; 2010 Mar; 7(3):273-84. PubMed ID: 20201734
[TBL] [Abstract][Full Text] [Related]
36. DNA repair alterations in common pediatric malignancies.
Papaefthymiou MA; Giaginis CT; Theocharis SE
Med Sci Monit; 2008 Jan; 14(1):RA8-15. PubMed ID: 18160950
[TBL] [Abstract][Full Text] [Related]
37. Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissue.
Bhavani V; Srinivasulu M; Ahuja YR; Hasan Q
Cancer Biomark; 2009; 5(4):207-13. PubMed ID: 19729830
[TBL] [Abstract][Full Text] [Related]
38. Overcoming drug resistance in patients with metastatic breast cancer.
Wong ST; Goodin S
Pharmacotherapy; 2009 Aug; 29(8):954-65. PubMed ID: 19637949
[TBL] [Abstract][Full Text] [Related]
39. Effect of DNA repair deficiencies on the cytotoxicity of drugs used in cancer therapy - a review.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; López-Lázaro M
Curr Med Chem; 2014; 21(30):3419-54. PubMed ID: 24934343
[TBL] [Abstract][Full Text] [Related]
40. Targeting the DNA Damage Response in Cancer.
O'Connor MJ
Mol Cell; 2015 Nov; 60(4):547-60. PubMed ID: 26590714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
